Scholars Central

Conference abstractPublished 28 Sep 2015

4-1BB as an immune target

Authors: Holbrook Kohrt

Stanford University, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Preclinical update on anti-CD137 Mab and Trastuzumab stimulation of natural killer cells with an anti-CD137 antibody enhances the efficacy of Trastuzumab, Cetuximab, and Rituximab in HER2-expressing breast cancer, EGFR+ head and neck cancer, and CD20+ lymphoma. My focus is on NK cells and translational research work that led from an initial in vitro observation to Phase 1 clinical studies. The starting observation was that primary human NK cells in the presence of a CD20-positive cell line and rituximab for 24 h upregulated CD137 (4-1BB) at their cell surface, and this upregulation was dependent on effective ADCC. The same observation was made with trastuzumab and cetuximab in the presence of HER-positive and EGFR-positive tumors, respectively. Using an agonistic anti-CD137 antibody, we demonstrate that triggering CD137 on NK cells enhanced the antitumor activity of rituximab, trastuzumab and cetuximab in vitro and in vivo. I will present various additional means to enhance ADCC by blocking inhibitory signals, such as CD47 on macrophages, IL-15 on monocytes or DCs, KIR or PD-1 on NK cells.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Clinical and Cellular Immunology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Cellular Immunology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Holbrook Kohrt”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels